Homeomunyl Influenzinum 9CH by Boiron - 4 Single-Dose Vials

$20.99
  • Estimated Delivery:Nov 29 - Dec 03

  • Free Shipping: for all orders over $40

STANDARD ITEM delivery in 7-14 days Click here for Shipping Policy
Homeomunyl Influenzinum 9CH by Boiron - 4 Single-Dose Vials

Homeomunyl Influenzinum 9CH by Boiron - 4 Single-Dose Vials

$20.99
Product Information

Presentation:
Homeomunyl is a homeopathic medicine traditionally recommended for supporting the body's natural defenses during the influenza season. It comes in the form of granules in single-dose vials.

Strain 2024-2025 Available Starting October 15, 2024.

The active ingredient in this homeopathic medicine is Influenzinum 9CH, which is prepared based on the influenza strains of the current year. The name "Influenzinum" is taken from "Influenza," the old scientific name for influenza viruses. While Homeomunyl is not a vaccine itself, it is made from the same strains used in the annual flu vaccine.

As flu strains evolve yearly, Influenzinum is updated to address the most prevalent strains expected for the upcoming flu season. Through a process of dilution and dynamization, the strains are transformed into a homeopathic solution. In this case, the strains have been diluted to the 9th centesimal potency (9CH), meaning the original strain has been diluted 9 times to one hundredth. The term CH refers to Centésimale Hahnemannienne, a scale named after Samuel Hahnemann, the founder of homeopathy.

Homeomunyl comes in a pack containing 4 single doses of Influenzinum 9CH. Other ingredients include lactose monohydrate and sucrose.


Recommended Dosage:

  • Take 1 single-dose vial per week for 3 consecutive weeks, starting in the fall.
  • A 4th dose should be taken one month after the 3rd dose.
  • Allow the entire contents of the vial to dissolve under the tongue, preferably in the morning on an empty stomach or at least away from meals.

Contraindications:

  • Not suitable for children under 6 years old.
  • Should not be used if you are allergic to any of the ingredients.
  • Avoid use if you have congenital galactosemia, glucose-galactose malabsorption syndrome, or lactase deficiency due to the presence of lactose. Similarly, avoid if you have fructose intolerance or sucrase-isomaltase deficiency due to the presence of sucrose.

Precautions:

  • Always inform your doctor or pharmacist if you are taking any other medications, including over-the-counter products.
  • If pregnant or breastfeeding, consult with your healthcare provider before using this product.

Contents:

  • 4 single-dose vials of Homeomunyl Influenzinum 9CH

This homeopathic product is designed to support your body's defense mechanisms during flu season but should not replace a flu vaccination or other medical treatments advised by your healthcare provider.

Please read the following full disclosure before taking or using this product.

Summary of Product Characteristics

ANSM - Last updated: 14/09/2023


1. NAME OF THE MEDICINE
Homéomunyl, granules in single-dose container.


2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Influenzinum 9 CH.......................................................................................................... 0.01 ml
For 1g of granules in a single-dose container.
Notable excipients: lactose and sucrose.
For the complete list of excipients, see section 6.1.


3. PHARMACEUTICAL FORM
Granules in single-dose container.


4. CLINICAL DATA

4.1. Therapeutic Indications
A homeopathic medicine traditionally used for the prevention of flu-like conditions.

4.2. Dosage and Method of Administration
This medicine is intended for adults and children over 6 years of age.

Dosage

  • Starting in the fall, take one dose per week for 3 weeks, followed by a 4th dose one month after the 3rd dose.

Method of Administration

  • Sublingual route.
  • Let the entire contents of a single-dose container dissolve under the tongue in the morning on an empty stomach or preferably away from meals.

4.3. Contraindications

  • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
  • Not for use in children under 6 years old.

4.4. Special Warnings and Precautions for Use

  • This medicine is not a vaccine.
  • Homeopathic treatment does not replace any specific treatment that may be required.
  • This medicine contains lactose, and its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
  • This medicine contains sucrose, and its use is not recommended in patients with fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency.

4.5. Interactions with Other Medicines and Other Forms of Interaction
Not applicable.

4.6. Fertility, Pregnancy, and Breastfeeding
Not applicable.

4.7. Effects on the Ability to Drive and Use Machines
Not applicable.

4.8. Undesirable Effects

  • Reporting suspected adverse reactions after authorization of the medicine is important. It allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals should report any suspected adverse reactions via the national reporting system: French National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.signalement-sante.gouv.fr.

4.9. Overdose
Not applicable.


5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic Properties
Pharmacotherapeutic class: Homeopathic medicine.
In the absence of clinical trials, the indication of this medicine is based on its traditional homeopathic use.

5.2. Pharmacokinetic Properties
Not applicable.

5.3. Preclinical Safety Data
Not applicable.


6. PHARMACEUTICAL DATA

6.1. List of Excipients
Lactose and sucrose.

6.2. Incompatibilities
Not applicable.

6.3. Shelf Life
12 months.

6.4. Special Precautions for Storage
No special storage precautions required.

6.5. Nature and Contents of the Container
Box containing 4 single-dose containers (polypropylene/polyethylene) of 1g each.

6.6. Special Precautions for Disposal and Handling
Not applicable.


7. MARKETING AUTHORIZATION HOLDER
BOIRON
2 Avenue de l’Ouest Lyonnais
69510 Messimy
France


8. MARKETING AUTHORIZATION NUMBER(S)
34009 357 475 3 2: granules in single-dose containers (PP/PE). Box of 4.


9. DATE OF FIRST AUTHORIZATION/RENEWAL OF AUTHORIZATION
[To be completed later by the holder]


10. DATE OF REVISION OF THE TEXT
[To be completed later by the holder]


11. DOSIMETRY
Not applicable.


12. INSTRUCTIONS FOR THE PREPARATION OF RADIOPHARMACEUTICALS
Not applicable.


PRESCRIPTION AND DISPENSING CONDITIONS
Medicine not subject to medical prescription.